# NCT04334941 (NCT04334941)

> Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04334941
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: National Cancer Institute (NCI)
- Conditions: Extensive Stage Lung Small Cell Carcinoma
- Interventions: Atezolizumab; Biopsy Procedure; Biospecimen Collection; Computed Tomography; Magnetic Resonance Imaging; Talazoparib
- Enrollment: 103
- Primary outcome: Progression free survival

## Commentary we found

- X threads: 34
- YouTube: 7
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct04334941

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04334941", "email": "<work email>"}; the inbox owner confirms by the emailed link.